EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Cécile CONTE •  chercheure

  • Conte C, Vayr F, Pajiep MC, Despas F, Huguet F, Mestre ML, Gauthier M, Herin F. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study. Support Care Cancer. 2022 Jun;30(6):5431-5440. doi: 10.1007/s00520-022-06968-w.
  • Paternoster M, Steichen O, Lapeyre-Mestre M, Blanchon T, Rossignol L, Vilcu AM, Launay T, Sarazin M, Bagheri H, Conte C, Turbelin C, Hanslik T, Souty C. Risk of Bleeding Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Exposed to Antithrombotic Therapy: A Case-Crossover Study. J Clin Pharmacol. 2022 May;62(5):636-645. doi: 10.1002/jcph.2003.
  • Strumia M, Perrin ML, Patras de Compaigno E, Conte C, Montastruc F, Lapeyre-Mestre M, Sibaud V, Despas F. Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®. Therapie. 2022 Mar-Apr;77(2):219-227. doi: 10.1016/j.therap.2021.12.006
  • Pajiep M, Conte C, Huguet F, Gauthier M, Despas F, Lapeyre-Mestre M. Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France. Front Oncol. 2021 Sep 30;11:675609. doi: 10.3389/fonc.2021.675609.
  • de Germay S, Conte C, Rascol O, Montastruc JL, Lapeyre-Mestre M. β-Adrenoceptor Drugs and Parkinson's Disease: A Nationwide Nested Case-Control Study. CNS Drugs. 2020 Jul;34(7):763-772. doi: 10.1007/s40263-020-00736-2.
  • Gauthier M, Conte C, Palmaro A, Patras De Campaigno E, De Barros S, Huguet F, Laurent G, Lapeyre-Mestre M, Despas F. Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in France. Fundam Clin Pharmacol. 2020 Oct;34(5):612-622. doi: 10.1111/fcp.12544.
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2020 Mar;23(3):235-242. doi: 10.1080/13696998.2019.1702990.